Naoki Yamamoto

Q: What Schools Are Affiliated With Naoki Yamamoto

Naoki Yamamoto is affiliated with the following schools: National University of Singapore, Nagasaki University, Kitasato University, Yamaguchi University, Kumamoto University, Kyoto University

Naoki Yamamoto's AcademicInfluence.com Rankings

Naoki Yamamoto

Biology

#12183

World Rank

#15641

Historical Rank

Cell Biology

#635

World Rank

#648

Historical Rank

Immunology

#808

World Rank

#831

Historical Rank

Molecular Biology

#1948

World Rank

#1979

Historical Rank

biology Degrees

Download Badge

Biology

Naoki Yamamoto's Degrees

PhD Molecular Biology University of Tokyo
Bachelors Biochemistry University of Tokyo

Why Is Naoki Yamamoto Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Naoki Yamamoto's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production (2008) (1656)
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. (1985) (838)
Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response (2009) (659)
Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. (2012) (537)
Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ (2004) (444)
Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. (1982) (398)
Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? (1991) (310)
Negative regulation of interferon-regulatory factor 3–dependent innate antiviral response by the prolyl isomerase Pin1 (2006) (309)
Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. (2002) (303)
Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling (2006) (287)
TWEAK Induces NF-κB2 p100 Processing and Long Lasting NF-κB Activation* (2003) (268)
Constitutive Activation of NF-κB in Primary Adult T-Cell Leukemia Cells (1999) (246)
Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. (2004) (241)
In vivo infection of human T-cell leukemia virus type I in non-T cells. (1993) (230)
Induction of Bcl-xL Expression by Human T-Cell Leukemia Virus Type 1 Tax through NF-κB in Apoptosis-Resistant T-Cell Transfectants with Tax (1999) (227)
Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4 (1986) (220)
Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV‐I‐associated myelopathy (1988) (213)
Differentiation and Enrichment of Hepatocyte‐Like Cells from Human Embryonic Stem Cells In Vitro and In Vivo (2007) (208)
A20 Is a Negative Regulator of IFN Regulatory Factor 3 Signaling1 (2005) (198)
Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. (2006) (193)
Hematopoietic stem cell–engrafted NOD/SCID/IL2Rγnull mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses (2007) (192)
A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. (2008) (188)
Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. (2011) (188)
A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity (2003) (159)
Differentiation of Human and Mouse Embryonic Stem Cells along a Hepatocyte Lineage (2004) (147)
Critical Contribution of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) to Apoptosis of Human Cd4+T Cells in HIV-1–Infected Hu-Pbl-Nod-Scid Mice (2001) (144)
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. (2003) (139)
Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. (1990) (136)
Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. (1999) (132)
Specific interaction of polypyrimidine tract-binding protein with the extreme 3'-terminal structure of the hepatitis C virus genome, the 3'X (1997) (131)
Unique cell lines harbouring both Epstein–Barr virus and adult T-cell leukaemia virus, established from leukaemia patients (1982) (124)
Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication (1989) (121)
Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB. (2003) (119)
Tumor promoter, TPA, enhances replication of HTLV-III/LAV. (1986) (114)
Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors (2014) (110)
Constitutive Activation Of Nf- κ B In Primary Adult T-cell Leukemia Cells (1999) (110)
Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. (1999) (106)
Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells. (2000) (106)
Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. (1989) (106)
Human T-cell Leukemia Virus Type I Tax Protein Induces the Expression of Anti-Apoptotic Gene Bcl-xL in Human T-Cells through Nuclear Factor-κB and c-AMP Responsive Element Binding Protein Pathways (2001) (104)
Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses. (2004) (104)
Rapid Tumor Formation of Human T-Cell Leukemia Virus Type 1-Infected Cell Lines in Novel NOD-SCID/γcnull Mice: Suppression by an Inhibitor against NF-κB (2003) (100)
Sera from adult T-cell leukemia patients react with envelope and core polypeptides of adult T-cell leukemia virus. (1984) (97)
Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300. (2001) (97)
Presence of HTLV‐I proviral DNA in central nervous system of patients with HTLV‐I–associated myelopathy (1992) (97)
Potential Role of NK Cells in the Induction of Immune Responses: Implications for NK Cell–Based Immunotherapy for Cancers and Viral Infections (2008) (95)
Human T-Cell Leukemia Virus Type 1 Tax Protein Abrogates Interleukin-2 Dependence in a Mouse T-Cell Line (1999) (95)
Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain (1997) (89)
Humanized NOD/SCID/IL2Rγnull Mice Transplanted with Hematopoietic Stem Cells under Nonmyeloablative Conditions Show Prolonged Life Spans and Allow Detailed Analysis of Human Immunodeficiency Virus Type 1 Pathogenesis (2007) (86)
Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells. (2004) (85)
Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events. (1985) (83)
Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. (2007) (80)
In Vivo and In Vitro Studies Suggest a Possible Involvement of HPV Infection in the Early Stage of Breast Carcinogenesis via APOBEC3B Induction (2014) (79)
Role of the Specific Amino Acid Sequence of the Membrane-Spanning Domain of Human Immunodeficiency Virus Type 1 in Membrane Fusion (2005) (78)
Increases in helper induced T cells and activated T cells in HTLV‐I–associated myelopathy (1989) (78)
T cell-mediated control of Epstein-Barr virus infection in humanized mice. (2009) (77)
Human T-Cell Leukemia Virus Type I Tax Transactivates Human Interleukin 8 Gene through Acting Concurrently on AP-1 and Nuclear Factor-κB-like Sites (1998) (76)
Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection (2003) (76)
AFRICAN GREEN MONKEYS ARE INFECTED WITH ADULT T-CELL LEUKAEMIA VIRUS OR A CLOSELY RELATED AGENT (1983) (75)
Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro (1990) (72)
Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells. (2001) (72)
Induction of Protective Immune Responses against R5 Human Immunodeficiency Virus Type 1 (HIV-1) Infection in hu-PBL-SCID Mice by Intrasplenic Immunization with HIV-1-Pulsed Dendritic Cells: Possible Involvement of a Novel Factor of Human CD4+ T-Cell Origin (2003) (71)
Adult T‐cell leukemia (ATL) virus‐specific antibodies in atl patients and healthy virus carriers (1983) (71)
Monoclonal antibody reactive with both p28 and p19 of adult T-cell leukemia virus-specific polypeptides. (1983) (70)
Mycoplasma can enhance HIV replication in vitro: a possible cofactor responsible for the progression of AIDS. (1990) (70)
Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness. (2002) (69)
Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization (1994) (69)
Priming-Boosting Vaccination with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin and a Nonreplicating Vaccinia Virus Recombinant Leads to Long-Lasting and Effective Immunity (2005) (68)
Zinc-finger antiviral protein mediates retinoic acid inducible gene I–like receptor-independent antiviral response to murine leukemia virus (2013) (67)
Epstein-Barr Virus Induces Erosive Arthritis in Humanized Mice (2011) (67)
Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo (2007) (65)
Retinoic acid inhibition of Epstein-Barr virus induction (1979) (65)
Viral aetiology of adult T-cell leukaemia. (1985) (63)
Altered subsets of peripheral blood lymphocytes in patients with HTLV‐I associated myelopathy (HAM) (1988) (63)
A novel NF‐κB inhibitor DHMEQ selectively targets constitutive NF‐κB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo (2005) (63)
The Novel CXCR4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection: Comparative Studies with AMD3100 (2009) (62)
Tumour promoter TPA enhances transformation of human leukocytes by Epstein–Barr virus (1979) (61)
Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB. (2003) (59)
Lymphotoxin‐β receptor mediates NEMO‐independent NF‐κB activation (2002) (58)
Apoptosis Induced by the Histone Deacetylase Inhibitor FR901228 in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells (2004) (58)
Ligand‐independent higher‐order multimerization of CXCR4, a G‐protein‐coupled chemokine receptor involved in targeted metastasis (2009) (57)
Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation. (1979) (57)
Selective cytotoxicity of aids virus infection towards HTLV‐I‐transformed cell lines (1985) (54)
Retrovirus Entry by Endocytosis and Cathepsin Proteases (2012) (54)
Sequential Immunization with V3 Peptides from Primary Human Immunodeficiency Virus Type 1 Produces Cross-Neutralizing Antibodies against Primary Isolates with a Matching Narrow-Neutralization Sequence Motif (2006) (54)
Identification of the target cells in human B lymphocytes for transformation by Epstein-Barr virus. (1977) (54)
Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo (1997) (54)
Vaccination of Rhesus Macaques with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Env V3 Elicits Neutralizing Antibody-Mediated Protection against Simian-Human Immunodeficiency Virus with a Homologous but Not a Heterologous V3 Motif (2005) (51)
Establishment of a high production system for AIDS retroviruses with a human T-leukemic cell line Molt-4. (1986) (51)
Sensitive assay for neutralizing antibodies against AIDS-related viruses (HTLV-III/LAV). (1986) (51)
Enhancement of HIV replication and giant cell formation by tumor necrosis factor. (1989) (50)
Determinant in Human Immunodeficiency Virus Type 1 for Efficient Replication under Cytokine-Induced CD4+ T-Helper 1 (Th1)- and Th2-Type Conditions (1999) (50)
Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells. (1999) (50)
Natural killer cells in breast cancer cell growth and metastasis in SCID mice. (2005) (50)
Novel Mouse Xenograft Models Reveal a Critical Role of CD4+ T Cells in the Proliferation of EBV-Infected T and NK Cells (2011) (49)
Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients. (1998) (49)
Activation of cyclin D1 and D2 promoters by human T‐cell leukemia virus type I tax protein is associated with IL‐2–independent growth of T cells (2002) (48)
The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway. (1990) (48)
High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells (1997) (47)
Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients. (2009) (47)
Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication. (2008) (46)
Ezrin, Radixin, and Moesin (ERM) proteins function as pleiotropic regulators of human immunodeficiency virus type 1 infection. (2008) (45)
Persistent infection of BHK21/WI-2 cells with rubella virus and characterization of rubella variants (2005) (44)
cAMP stimulates human immunodeficiency virus (HIV-1) from latently infected cells of monocyte-macrophage lineage: synergism with TNF-alpha. (1993) (44)
Influence of Glycosylation on the Efficacy of an Env-Based Vaccine against Simian Immunodeficiency Virus SIVmac239 in a Macaque AIDS Model (2005) (44)
Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells. (2001) (43)
Anti-V3 Humanized Antibody KD-247 Effectively Suppresses Ex Vivo Generation of Human Immunodeficiency Virus Type 1 and Affords Sterile Protection of Monkeys against a Heterologous Simian/Human Immunodeficiency Virus Infection (2006) (41)
Serum level of TNF alpha in HIV-infected individuals. (1990) (40)
Activation of oncogenic transcription factor AP-1 in T cells infected with human T cell leukemia virus type 1. (2000) (40)
Human T-cell leukemia virus type 1 Tax protein induces the expression of lymphocyte chemoattractant SDF-1/PBSF. (1998) (40)
Adult T-Cell Leukemia-Associated Antigen (ATLA): Detection of a Glycoprotein in Cell- and Virus-Free Supernatant (1982) (38)
High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection. (1997) (38)
Mycobacterial Codon Optimization Enhances Antigen Expression and Virus-Specific Immune Responses in Recombinant Mycobacterium bovis Bacille Calmette-Guérin Expressing Human Immunodeficiency Virus Type 1 Gag (2005) (37)
Effect of heat and fresh human serum on the infectivity of human T-cell lymphotropic virus type III evaluated with new bioassay systems (1985) (37)
Sequence heterogeneity of HTLV‐I proviral DNA in the central nervous system of patients with HTLV‐I–associated myelopathy (1994) (37)
Human T-cell leukemia virus type 1 Tax protein induces the expression of STAT1 and STAT5 genes in T-cells (1999) (36)
Elevated expression of CCL5/RANTES in adult T‐cell leukemia cells: Possible transactivation of the CCL5 gene by human T‐cell leukemia virus type I tax (2004) (36)
Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analogues. (2011) (36)
Epstein-Barr virus-induced proteins. II. Analysis of surface polypeptides from EBV-producing and -superinfected cells by immunoprecipitation. (1980) (35)
Role of human herpesvirus 6 infection in infants with exanthema subitum. (1990) (35)
Separate elements are required for ligand‐dependent and ‐independent internalization of metastatic potentiator CXCR4 (2007) (34)
A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo. (2005) (34)
Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection. (2009) (34)
A Consecutive Priming-Boosting Vaccination of Mice with Simian Immunodeficiency Virus (SIV) gag/pol DNA and Recombinant Vaccinia Virus Strain DIs Elicits Effective Anti-SIV Immunity (2004) (33)
Combined intrarectal/intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen. (2002) (32)
A novel role for Vpr of human immunodeficiency virus type 1 as a regulator of the splicing of cellular pre-mRNA. (2005) (32)
Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression. (1989) (31)
Infectivity dissociated from transforming activity in a human retrovirus, adult T-cell leukemia virus. (1982) (31)
Aberrant NF-κB2/p52 expression in Hodgkin/Reed–Sternberg cells and CD30-transformed rat fibroblasts (2005) (30)
A Novel Small Molecular Weight Compound with a Carbazole Structure That Demonstrates Potent Human Immunodeficiency Virus Type-1 Integrase Inhibitory Activity (2005) (30)
Clonal selection of human immunodeficiency virus (HIV): serological differences in the envelope antigens of the cloned viruses and HIV prototypes (HTLV-III B, LAV, and ARV). (1987) (30)
Macrophage response to oncolytic paramyxoviruses potentiates virus‐mediated tumor cell killing (2016) (30)
An IκB kinase 2 inhibitor IMD‐0354 suppresses the survival of adult T‐cell leukemia cells (2012) (30)
Molecular cloning of cDNA encoding gp68 of adult T-cell leukaemia-associated antigen: evidence for expression of the pX IV region of human T-cell leukaemia virus. (1985) (30)
Co-infection with human immunodeficiency virus and tuberculosis in Asia. (2007) (30)
Induction of Monocyte Chemoattractant Protein 1 byHelicobacter pylori Involves NF-κB (2001) (29)
Role for protein geranylgeranylation in adult T-cell leukemia cell survival. (2009) (29)
Human T-Cell Leukemia Virus Type I Tax Activates Transcription of the Human Monocyte Chemoattractant Protein-1 Gene through Two Nuclear Factor-κB Sites (2000) (29)
The prolyl isomerase Pin1 stabilizes the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein and promotes malignant transformation. (2009) (28)
Nuclear Import of the Preintegration Complex Is Blocked upon Infection by Human Immunodeficiency Virus Type 1 in Mouse Cells (2006) (28)
CD4-Independent Human Immunodeficiency Virus Infection Involves Participation of Endocytosis and Cathepsin B (2011) (28)
Derivatives of 5-nitro-furan-2-carboxylic acid carbamoylmethyl ester inhibit RNase H activity associated with HIV-1 reverse transcriptase. (2009) (28)
Repression of Smad‐dependent transforming growth factor‐β signaling by Epstein‐Barr virus latent membrane protein 1 through nuclear factor‐κB (2003) (28)
Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells. (2010) (28)
A novel agglutination test for the human immunodeficiency virus antibody: a comparative study with enzyme-linked immunosorbent assay and immunofluorescence. (1986) (28)
Evaluation of passive particle agglutination test for antibody to human immunodeficiency virus (1987) (27)
Lymphotoxin-beta receptor mediates NEMO-independent NF-kappaB activation. (2002) (27)
Differential inducibility of Epstein‐Barr virus in cloned, non‐producer raji cells (1979) (27)
Essential Role of Transcription Factor Nuclear Factor-κB in Regulation of Interleukin-8 Gene Expression by Nitrite Reductase from Pseudomonas aeruginosa in Respiratory Epithelial Cells (1999) (27)
Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity. (2007) (27)
Productive and lytic infection of human CD4+ type 1 helper T cells with macrophage-tropic human immunodeficiency virus type 1 (1997) (26)
Quantitative evaluations of the effect of UV irradiation on the infectivity of HTLV-III (AIDS virus) with HTLV-I-carrying cell line, MT-4. (1986) (26)
Expression of HTLV-I antigen in cultured peripheral blood mononuclear cells from patients with HTLV-I associated myelopathy (1988) (26)
Erratum: Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: A quantitative polymerase chain reaction study (Ann Neurol (Feb. 1991) 29 (194-201)) (1991) (25)
Helicobacter pylori Induces RANTES through Activation of NF-κB (2003) (25)
Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55Gag with the phospholipase C-δ1 pleckstrin homology domain results in infectious pseudovirion production (2008) (25)
Expression of Epstein-Barr virus in mesopharyngeal and hypopharyngeal carcinomas. (1999) (24)
A Single-Nucleotide Synonymous Mutation in the gag Gene Controlling Human Immunodeficiency Virus Type 1 Virion Production (2006) (24)
DEFECTIVE HUMAN IMMUNO‐DEFICIENCY VIRUS (HIV) PARTICLES PRODUCED BY CLONED CELLS OF HTLV‐I‐CARRYING MT‐4 CELLS PERSISTENTLY INFECTED WITH HIV (1988) (24)
Epstein-Barr Virus Nuclear Antigen Leader Protein Induces Expression of Thymus- and Activation-Regulated Chemokine in B Cells (2004) (24)
Infection of human CD4+ rabbit cells with HIV-1: the possibility of the rabbit as a model for HIV-1 infection. (1991) (23)
Translation of HTLV (human T‐cell leukemia virus) RNA in a nuclease‐treated rabbit reticulocyte system. (1984) (23)
HTLV-II in patients with HTLV-I-associated myelopathy (1991) (23)
Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach (2011) (23)
Altered interleukin‐2 receptor α‐chain is expressed in human T‐cell leukaemia virus type‐I‐infected T‐cell lines and human peripheral blood mononuclear cells of adult T‐cell leukaemia patients through an alternative splicing mechanism (1997) (22)
Induction of Positive Cellular and Humoral Immune Responses by a Prime-Boost Vaccine Encoded with Simian Immunodeficiency Virus gag/pol1 (2006) (22)
Characterization of african green monkey B‐cell lines releasing an adult T‐cell leukemia‐virus‐related agent (1984) (22)
Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy. (1989) (22)
Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-kappaB-like sites. (1998) (22)
Quantitative analysis of AIDS-related virus-carrying cells by plaque-forming assay using an HTLV-I-positive MT-4 cell line. (1985) (22)
Evidence for hybrid formation between rubella virus and a latent virus of BHK21/WI-2 cells. (1976) (21)
Augmentation of cytotoxic effect of tumor necrosis factor on human immunodeficiency virus-infected cells by staurosporine, a potent protein kinase C inhibitor. (1990) (21)
Inhibiting lentiviral replication by HEXIM1, a cellular negative regulator of the CDK9/cyclin T complex (2007) (21)
Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry (2007) (21)
Potential role of natural killer cells in controlling growth and infiltration of AIDS‐associated primary effusion lymphoma cells (2006) (20)
Prompt tumor formation and maintenance of constitutive NF‐κB activity of multiple myeloma cells in NOD/SCID/γCnull mice (2004) (20)
Use of New T-Cell-Based Cell Lines Expressing Two Luciferase Reporters for Accurately Evaluating Susceptibility to Anti-Human Immunodeficiency Virus Type 1 Drugs (2006) (20)
Infection of XC Cells by MLVs and Ebola Virus Is Endosome-Dependent but Acidification-Independent (2011) (20)
Induction of apoptosis in Epstein-Barr virus-infected B-lymphocytes by the NF-kappaB inhibitor DHMEQ. (2008) (19)
Novel two-parameter flow cytometry (MIL4/SSC followed by MIL4/CT7) allows for identification of five fractions of guinea pig leukocytes in peripheral blood and lymphoid organs. (2006) (19)
A New Monoclonal Antibody Recognizing an Antigen of Human Lymphocytes Similar or Identical to Tac Antigen (1984) (19)
EFFECT OF CULTURE SUPERNATANT OF MT‐2 CELLS ON HUMAN IMMUNODEFICIENCY VIRUS‐PRODUCING CELLS, MOLT‐4/HIVHTLV‐IIIB CELLS (1988) (18)
Cathepsin L is required for ecotropic murine leukemia virus infection in NIH3T3 cells (2009) (18)
High SDF-1 expression in HIV-1 carriers does not correlate with CD8+ T-cell-mediated suppression of viral replication. (1998) (18)
Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells. (2007) (17)
Effect of actinomycin D and cycloheximide on Epstein-Barr virus early antigen induction in lymphoblastoid cells. (1980) (17)
Cross-Linking Cell Surface Chemokine Receptors Leads to Isolation, Activation, and Differentiation of Monocytes into Potent Dendritic Cells (2006) (17)
Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor‐κB activity in unconditioned NOD/SCID/γcnull mice (2005) (17)
Identification of the P‐TEFb complex‐interacting domain of Brd4 as an inhibitor of HIV‐1 replication by functional cDNA library screening in MT‐4 cells (2008) (17)
Adenovirus‐mediated Transfer of Fas Ligand Gene Augments Radiation‐induced Apoptosis in U‐373MG Glioma Cells (2000) (16)
Precursor polypeptides of adult T-cell leukaemia virus: detection with antisera against isolated polypeptides gp68, p24 and p19. (1984) (16)
Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB. (2003) (16)
The interaction of HIV-1 with the host factors. (2005) (16)
Elevated serum antibody titers to Epstein‐Barr virus in HTLV‐I‐associated myelopathy (HAM) (1988) (16)
IκBα independent induction of NF-κB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells (2007) (16)
Terminal rearrangements in the genome of adenovirus type 12 mutants adapted to growth in two human tumor cell lines. (1982) (16)
An optimal culture condition maintains human hepatocyte phenotype after long-term culture. (2006) (16)
Inhibition of IkappaB kinase beta restrains oncogenic proliferation of pancreatic cancer cells. (2008) (16)
Lysis of human immunodeficiency virus infected cells by TPA-type and non-TPA type tumor promoters. (1988) (15)
Humanized mice for human retrovirus infection. (2008) (15)
Epstein-Barr virus-induced proteins. III. Analysis of polypeptides from P3HR-1-EBV-superinfected NC37 cells by immunoprecipitation. (1980) (15)
Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD/SCID/gammac(null) mice. (2005) (15)
Effect of heat and fresh human serum on the infectivity of human T-cell lymphotropic virus type III evaluated with new bioassay systems. (1985) (15)
Identification of the suppressive factors for human immunodeficiency virus type-1 replication using the siRNA mini-library directed against host cellular genes. (2007) (15)
In vitro infection of human B lymphocytes with adult T-cell leukemia virus. (1984) (15)
Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites. (2000) (14)
Human T-Cell Leukemia Virus I Induction by 5-lodo-2′-deoxyuridine and N-Methyl-N′-nitro-N-nitrosoguanidine: Inhibition by Retinoids, l-Ascorbic Acid, and dl-α-Tocopherol (1985) (14)
Effects of succinylated concanavalin A on infectivity and syncytial formation of human immunodeficiency virus (2004) (14)
Spread and distribution of human T-cell leukaemia virus type I-reactive antibody among baboons and monkeys in the northern and eastern Transvaal. (1985) (14)
Upregulation of p21WAF1/CIP1 leads to morphologic changes and esterase activity in TPA-mediated differentiation of human prostate cancer cell line TSU-Pr1 (2001) (14)
Prompt tumor formation and maintenance of constitutive NF-kappaB activity of multiple myeloma cells in NOD/SCID/gammacnull mice. (2004) (14)
Distribution and possible spread of human T-cell leukaemia virus type I in human communities in the northern and eastern Transvaal. (1985) (14)
Pertussis toxin inhibits induction of human immunodeficiency virus type 1 in infected monocytes. (1994) (14)
A novel CD4‐conjugated ultraviolet light‐activated photocatalyst inactivates HIV‐1 and SIV efficiently (2008) (13)
Amplification of human immuno-deficiency virus production from a virus-producing cell line in culture at high cell density. (1987) (13)
Expression of HTLV-specific polypeptides in various human T-cell lines (2005) (13)
Correlation between high susceptibility to AIDS virus and surface expression of OKT-4 antigen in HTLV-I-positive cell lines. (1985) (13)
Comparison of effects of protein kinase C inhibitors on phorbol ester-induced CD4 down-regulation and augmentation of human immunodeficiency virus replication in human T cell lines. (1989) (13)
Entry of human immunodeficiency virus (HIV) into MT-2, human T cell leukemia virus carrier cell line (1988) (13)
Effect of inhibition of DNA synthesis on Epstein--Barr virus induction by tumor promoters. (1980) (13)
NF-κB is required for cell death induction by latent membrane protein 1 of Epstein-Barr virus (2003) (13)
28,000-dalton polypeptide (p28) of adult T-cell leukemia-associated antigen encoded by 24 S mRNA of human T-cell leukemia virus has an associated protein kinase activity. (1984) (13)
Adenovirus‐mediated Gene Transduction of IkB or IkB Plus Bax Gene Drastically Enhances Tumor Necrosis Factor (TNF)‐induced Apoptosis in Human Gliomas (2000) (12)
Narrow host range of AIDS-related retroviruses (YU-1, 2, 3, 4) isolated from Japanese hemophiliacs: inability to infect H9, Molt-4, and MT-4 cells. (1986) (12)
Comparative studies of commercially available particle agglutination assay and enzyme-linked immunosorbent assay for screening of human T-cell leukemia virus type I antibodies in blood donors (1988) (12)
Overexpressed NF- (cid:1) B–inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells (2008) (12)
Influence of Advanced Age on Mycobacterium bovis BCG Vaccination in Guinea Pigs Aerogenically Infected with Mycobacterium tuberculosis (2010) (12)
Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys. (2007) (12)
Enhancement of OX40-induced apoptosis by TNF coactivation in OX40-expressing T cell lines in vitro leading to decreased targets for HIV type 1 production. (2008) (12)
Differential inhibition of epstein‐barr virus induction by the amino acid analogue, L‐canavanine (1980) (12)
Retraction: Essential Role of Transcription Factor Nuclear Factor-κB in Regulation of Interleukin-8 Gene Expression by Nitrite Reductase from Pseudomonas aeruginosa in Respiratory Epithelial Cells (2011) (11)
Impact of glycosylation on antigenicity of simian immunodeficiency virus SIV239: induction of rapid V1/V2-specific non-neutralizing antibody and delayed neutralizing antibody following infection with an attenuated deglycosylated mutant. (2008) (11)
Determination of HIV type 1 CRF01_AE gag p17 and env-V3 consensus sequences for HIV/AIDS vaccine design. (2004) (11)
Hematopoietic stem cell – engrafted NOD / SCID / IL 2 R null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses (2006) (11)
Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine. (2004) (11)
Follicular dendritic cell sarcoma with microtubuloreticular structure and virus‐like particle production in vitro (2009) (11)
Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses. (2008) (11)
TUMOUR NECROSIS FACTOR AND HIV: A NOTE OF CAUTION (1988) (11)
Human adult T-cell leukaemia virus is distinct from a similar isolate of Japanese monkeys. (1984) (11)
Detection of antibodies to human T-lymphotropic viruses type I and III in Japanese hemophiliacs. (1983) (11)
Friend murine leukemia virus A8 regulates Env protein expression through an intron sequence. (2009) (11)
Adenovirus-mediated transfer of caspase-8 in combination with superrepressor of NF-kappaB drastically induced apoptosis in gliomas. (2000) (10)
Helicobacter pylori induces RANTES through activation of NF-kappa B. (2003) (10)
Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system. (1991) (10)
Induction of nuclear antigen (EBNA) synthesis without transformation in human cord lymphocytes by P3HR-1 strain of Epstein-Barr virus. (1978) (10)
TNF-beta produced by human T lymphotropic virus type I-infected cells influences the proliferation of human endothelial cells and fibroblasts. (1994) (10)
Development of a Monoclonal Antibody against Epstein‐Barr Virus Nuclear Antigen Leader Protein (EBNA‐LP) That Can Detect EBNA‐LP Expressed in P3HR1 Cells (2005) (10)
In Vivo and In Vitro Studies Suggest a Possible Involvement of HPV Infection in the Early Stage of Breast Carcinogenesis via APOBEC 3 B Induction (2014) (9)
Inhibitory role of CXCR4 glycan in CD4-independent X4-tropic human immunodeficiency virus type 1 infection and its abrogation in CD4-dependent infection. (2007) (9)
Determinant for the inhibition of ecotropic murine leukemia virus infection by N-linked glycosylation of the rat receptor. (2004) (9)
Intradermal Delivery of Recombinant Vaccinia Virus Vector DIs Induces Gut‐Mucosal Immunity (2010) (9)
Immune response of patients with exanthema subitum to human herpesvirus type 6 (HHV-6) polypeptides. (1989) (9)
Transformation of tonsil lymphocytes by Epstein-Barr virus. (1976) (9)
Rapid Propagation of Low-Fitness Drug-Resistant Mutants of Human Immunodeficiency Virus Type 1 by a Streptococcal Metabolite Sparsomycin (2006) (9)
Mycoplasma stimulates HIV-1 expression from acutely- and dormantly-infected promonocyte/monoblastoid cell lines (2005) (9)
THIS ARTICLE HAS BEEN RETRACTED Epstein–Barr virus‐encoded latent membrane protein 1 activates β‐catenin signaling in B lymphocytes (2009) (9)
Transmission and genetic shift of human immunodeficiency virus (HIV) in vivo. (1987) (9)
CXCR4-tropic, but not CCR5-tropic, human immunodeficiency virus infection is inhibited by the lipid raft-associated factors, acyclic retinoid analogs, and cholera toxin B subunit. (2012) (8)
Experimental infection of cynomolgus monkeys with a human retrovirus, adult T-cell leukemia virus (2005) (8)
Multiplication and distribution of type 2 dengue and Japanese encephalitis viruses in Toxorhynchites splendens after intrathoracic inoculation (2005) (8)
Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide. (1981) (8)
Mechanisms underlying glycosylation-mediated loss of ecotropic receptor function in murine MDTF cells and implications for receptor evolution. (2008) (8)
Postinfection passive transfer of KD-247 protects against simian/human immunodeficiency virus-induced CD4+ T-cell loss in macaque lymphoid tissue (2009) (8)
Follicular Dendritic Cells Activate HIV-1 Replication in Monocytes/Macrophages through a Juxtacrine Mechanism Mediated by P-Selectin Glycoprotein Ligand 11 (2009) (8)
Binding of adult T-cell leukemia virus to various hematopoietic cells. (1984) (8)
Anti-V 3 Humanized Antibody KD-247 Effectively Suppresses Ex Vivo Generation of Human Immunodeficiency Virus Type 1 and Affords Sterile Protection of Monkeys against a Heterologous Simian / Human Immunodeficiency Virus Infection (2006) (8)
Intravenous Inoculation of Replication-Deficient Recombinant Vaccinia Virus DIs Expressing Simian Immunodeficiency Virus Gag Controls Highly Pathogenic Simian-Human Immunodeficiency Virus in Monkeys (2003) (7)
The normalization of guinea pig leukocyte fractions and lymphocyte subsets in blood and lymphoid tissues using a flow cytometric procedure. (2004) (7)
Characterization of human B-cell lines harbouring both adult T-cell leukaemia (ATL) virus and Epstein-Barr virus derived from ATL patients. (1984) (7)
A recessive mutant cell line with a constitutive IκB kinase activity (2002) (7)
Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor b signaling through interaction with CREB-binding protein / p 300 (2001) (7)
Immunogenicity of newly constructed attenuated vaccinia strain LC16m8Delta that expresses SIV Gag protein. (2009) (7)
Induction of Epstein-Barr virus early antigens by intercalating chemicals in B95-8 cells. (1981) (7)
Inhibition of human T-cell leukemia virus type 1 replication by antisense env oligodeoxynucleotide. (1998) (7)
Distinct IkappaB kinase regulation in adult T cell leukemia and HTLV-I-transformed cells. (2005) (7)
Phenotype and function of GM-CSF independent dendritic cells generated by long-term propagation of rat bone marrow cells. (2004) (7)
Evaluation of anti-human immunodeficiency virus effect of recombinant CD4-immunoglobulin in vitro: a good candidate for AIDS treatment (2004) (7)
Quantitative analysis of cytotoxicity induced by HTLV-I carrying cells against a human lymphoblastoid cell line, Molt-4. (1987) (7)
IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells. (2007) (7)
Structural analysis of p19 and p24 core polypeptides of primate lymphotropic retroviruses (PLRV). (1986) (7)
Detection and isolation of an acquired immune deficiency syndrome (AIDS)-related virus (HTLV-III/LAV) from a Japanese boy with AIDS-related complex. (1986) (6)
Characterization of 17 Human Immunodeficiency Virus-1 Carrier Cell Lines with T cell, Myelomonocyte, or Megakaryocyte Lineages (1993) (6)
A simple competitive RT-PCR assay for quantitation of HIV-1 subtype B and non-B RNA in plasma. (2007) (6)
Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines. (1982) (6)
Acquisition of HIV type 1 resistance by beta-chemokine-producing CD4+ T cells. (1999) (6)
Recombinant Vaccinia DIs Expressing Simian Immunodeficiency Virus Gag and Pol in Mammalian Cells Induces Efficient Cellular Immunity as a Safe Immunodeficiency Virus Vaccine Candidate (2006) (6)
Enhancement of human immunodeficiency virus production by natural lymphotoxin (2004) (5)
Epitope analysis of the cerebrospinal fluid IgG in HTLV-I associated myelopathy patients using phage display method (2004) (5)
Intravenous Inoculation of Replication-DeficientRecombinant Vaccinia Virus DIs Expressing Simian ImmunodeficiencyVirus Gag Controls Highly Pathogenic Simian-HumanImmunodeficiency Virus inMonkeys (2003) (5)
NF-kappaB is required for cell death induction by latent membrane protein 1 of Epstein-Barr virus. (2003) (5)
Cyclin K/CPR4 inhibits primate lentiviral replication by inactivating Tat/positive transcription elongation factor b-dependent long terminal repeat transcription (2008) (5)
The association of antibodies against human T cell lymphotropic virus type I (HTLV-I) pX gene mutant products with HTLV-I-associated myelopathy/tropical spastic paraparesis. (1996) (5)
Virus induction by tumor promoters. (1982) (5)
Induction of chronic inflammatory arthropathy and mesenchymal tumors in rats infected with HTLV-I. (1997) (5)
Constitutive Activation of NFk B in Primary Adult T-Cell Leukemia Cells (1999) (5)
Effect of retinoic acid on the replication of human immunodeficiency virus in HTLV-I-positive MT-4 cells (1987) (5)
Identification of HIV-1 Epitopes that Induce the Synthesis of a R5 HIV-1 Suppression Factor by Human CD4+ T Cells Isolated from HIV-1 Immunized Hu-PBL SCID Mice (2005) (5)
Viability of infectious viral particles of HIV and BMCs in breast milk. (2007) (5)
Phylogenetic heterogeneity of new HTLV type 1 isolates from southern India in subgroup A. (2005) (5)
Augmentation and stable expression of a novel transcription factor SII in CD4-positive cells on infection with human immunodeficiency virus type-1 (HIV-1). (1988) (4)
Interleukin‐15 stimulates the proliferation of peripheral blood leukemic cells from adult T‐cell leukemia patients (1998) (4)
Improvement of lentiviral vector-mediated gene transduction by genetic engineering of the structural protein Pr55Gag (2010) (4)
AIDS studies in Japan. (1987) (4)
Structural and epidemiological features of primate lymphotropic retroviruses. (1984) (4)
Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus. (2014) (4)
Priming-Boosting Vaccination with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin and a Nonreplicating Vaccinia Virus Recombinant Leads to Long-Lasting and Effective Immunity (2006) (4)
Mutational analysis of the 5' noncoding region of human immunodeficiency virus type 1 genome. (1997) (4)
Relationship of human cord blood mononuclear cell lines, established by the HTLV-I integration, to expression of T-cell phenotypes and the T-cell receptor gene rearrangement. (1987) (3)
Pertussis toxin enhances human immunodeficiency virus type 1 replication. (2000) (3)
Replication-defective HIV isolated from seronegative individuals at high risk for HIV infection. (2005) (3)
specific humoral immune responses human lymphoid systems and induce long-lasting HIV-1 infection with null mice develop γ engrafted NOD/SCID/IL2R - Hematopoietic stem cell (2013) (3)
The Novel CXCR 4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection : Comparative Studies with AMD 3100 (2009) (3)
Isolation and characterization of a new rubella variant with DNA polymerase activity (2005) (3)
Characterization of human T-cell lines harboring defective human immunodeficiency virus type 1 (1989) (3)
Mouse serum factor(s) down-modulate the CD4 and CXCR4 molecules on human T cells conferring resistance to HIV infection in NOG mice (2005) (3)
Regulation of the susceptibility of HIV-1 to a neutralizing antibody KD-247 by nonepitope mutations distant from its epitope (2011) (3)
Transformation of leukocytes from seropositive individuals by Epstein-Barr virus. (1976) (3)
Activity of superior interferon α against HIV-1 in severe combined immunodeficient mice reconstituted with human peripheral blood leukocytes. (2011) (3)
Effect of HTLV-III on the macromolecular synthesis in HTLV-I carrying cell line, MT-4 (1986) (3)
Inhibitory Mechanism of the CXCR4 Antagonist T22 against Human Immunodeficiency Virus Type 1 Infection (1999) (3)
Mucosal Administration of Completely Non‐Replicative Vaccinia Virus Recombinant Dairen I strain Elicits Effective Mucosal and Systemic Immunity (2008) (2)
Structural gene products and morphogenesis of a hybrid between rubella virus and a hamster latent retrovirus. (1993) (2)
Hybrids between rubella virus and a latent virus of baby hamster kidney cell line BHK21: characterization of rubella virus and type 2 hybrid virus genomes and determination of their physical homology. (1990) (2)
A recessive mutant cell line with a constitutive IkappaB kinase activity. (2002) (2)
Effect of pH on giant cell formation induced by human immunodeficiency virus ( HIV ). (1989) (2)
Human T-cell leukemia virus I induction by 5-iodo-2'-deoxyuridine and N-methyl-N'-nitro-N-nitrosoguanidine: inhibition by retinoids, L-ascorbic acid, and DL-alpha-tocopherol. (1985) (2)
Induction of Monocyte Chemoattractant Protein 1 by Helicobacter pylori Involves NF-κB (2011) (2)
Apoptosis Induced by the Histone Deacetylase Inhibitor FR901228 in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells (2011) (2)
Short Communication Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55 Gag with the phospholipase C-d1 pleckstrin homology domain results in infectious pseudovirion production (2008) (2)
Clonal analysis of functional differences among strains of human immunodeficiency virus (HIV). (1987) (2)
[Detection of adult T-cell leukemia virus and ATLV antibodies]. (1986) (2)
Suppression by neurotropin of production of human immuno-deficiency virus by the virus-producing MOLT-4 cell line. (1987) (2)
Autonomous Proliferation of HTLV−CD4+ T Cell Clones Derived from Human T Cell Leukemia Virus Type I (HTLV‐I)‐Associated Myelopathy Patients (2007) (2)
Retroviridae: Human T-Lymphotropic Virus-I (HTLV-I)/Adult T-CeU Leukemia Virus (ATLV) (1988) (1)
Retraction. Essential role of transcription factor nuclear factor-κB in regulation of interleukin-8 gene expression by nitrite reductase from Pseudomonas aeruginosa in respiratory epithelial cells. (2011) (1)
Analysis of cis‐regulatory elements in the 5′ untranslated region of murine leukemia virus controlling protein expression (2008) (1)
Fractionation of guinea pig leukocyte by flow cytometry using a novel MIL4/SSC parameter (2003) (1)
[Quantitation of and neutralizing antibodies to AIDS-retroviruses; a novel system using HTLV-I carrying MT-4 cells]. (1985) (1)
P-Selectin Glycoprotein Ligand 1 through a Juxtacrine Mechanism Mediated Replication in Monocytes / Macrophages Follicular Dendritic Cells Activate HIV-1 (2009) (1)
[HIV infection and long-term non progressor]. (1997) (1)
Japan’s Collaboration with Thailand in the Development of an HIV/AIDS Vaccine (2004) (1)
Abnormalities of peripheral blood lymphocytes in HTLV-I associated myelopathy (1987) (1)
Leukemia Cells T-Cell Lines and Primary Adult T-Cell T-Cell Leukemia Virus Type 1-Infected Deacetylase Inhibitor FR 901228 in Human Apoptosis Induced by the Histone (2004) (1)
HTLV-I-reactive antibody in the northern and eastern Transvaal. (1985) (1)
Nature of Adult T‐Cell Leukemia‐Associated Membrane Antigen on the Surface of Adult T‐Cell Leukemia Virus‐Carrying Cells as Revealed by Membrane Immunofluorescence (1984) (1)
This article has been retracted: Epstein–Barr virus‐encoded latent membrane protein 1 activates β‐catenin signaling in B lymphocytes (2011) (1)
Production of tumor necrosis factors by human T cell lines infected with HTLV-1 may cause their high susceptibility to human immunodeficiency virus infection (2004) (1)
Potential role of NK cells in tumor growth and metastasis of breast cancer cells in NOD/SCID/γcnull (NOG) mice: Implication of immune therapy (2005) (1)
Is TNF involved in the progression of AIDS? (1990) (1)
[Gelatin particle agglutination test for serum antibodies to HIV]. (1988) (1)
Inhibitory role of CXCR 4 glycan in CD 4-independent X 4-tropic human immunodeficiency virus type 1 infection and its abrogation in CD 4-dependent infection (2007) (0)
STUDIES ON THE MOST EFFICIENT VECTOR SYSTEMS FOR GENE TRANSDUCTION INTO DENDRITIC CELLS (DC) (2004) (0)
Erratum: Helicobacter pylori induces RANTES through activation of NF-κB (Infection and Immunity (2003) 71:7 (3748-3756)) (2011) (0)
Detection of human immunodeficiency virus (HIV) in cultures of lymphocytes from HIV-seropositive persons with special reference to an enzyme immunoassay. (1989) (0)
99. Use of a Liver-Specific Lentivirus Vector for Characterization of Hepatocyte-Like Cells from Human Differentiated Embryonic Stem Cells (hESC) (2005) (0)
[Drug delivery system (DDS) for the use of antisense oligodeoxynucleotide phosphorothioate in controlling gene expression]. (1998) (0)
Multiplication and distribution of type 2 dengue and Japanese encephalitis viruses inToxorhynchites splendens after intrathoracic inoculation (2005) (0)
Human T-Cell Leukemia Virus Type I Tax Activates Transcription of the Human Monocyte Chemoattractant Protein-1 Gene through Two Nuclear Factor-k B Sites (2000) (0)
Plaque Staining AssayforNon-or WeaklyCytotoxic HumanImmunodeficiency Virus (1987) (0)
Humanized NOD/SCID/IL2R γ -/- mice model for human retroviral and EBV infection (2008) (0)
Erratum: Induction of monocyte chemoattractant protein 1 by helicobacter pylori involves NF-κB (Infection and Immunity (2001) 69:3 (1280-1286)) (2011) (0)
Studies on the most efficient vector systems for gene transduction into dendritic cells. (2005) (0)
Tax-Independent Constitutive I n B Kinase Activation in Adult T-Cell Leukemia Cells 1 (2004) (0)
Is cyclin-dependent kinase 9 a novel specific molecular target of adult T-cell leukemia/lymphoma? (2018) (0)
Development of HIV Infectious Diseases Integrated Database (2004) (0)
Inhibition of syncytium formation by antisense oligonucleotide phosphorothioates complementary to tax mRNA of human T-cell leukemia virus type 1 (HTLV-1). (1997) (0)
Isolation and Charaeterization of a New Rubella Variant With DNA Polymerase Aetivity (1978) (0)
103: Identification of a novel interferon-stimulated gene whose product significantly restricts retrovirus replication (2014) (0)
gag/pol Virus Encoded with Simian Immunodeficiency Vaccine Immune Responses by a Prime-Boost Induction of Positive Cellular and Humoral (2006) (0)
Helicobacter pylori Induces RANTES through Activation of NF-κB (2011) (0)
distribution of human T-cell type I-reactive antibody in the Transvaal (1985) (0)
Effect of Concanavalin A on the infectivity of rubella virus and its variants (2005) (0)
Effect of pinching node and number of branches on the rosette formation, growth and flowering of Gypsophila paniculata L. (1996) (0)
[Evaluation of the passive particle aggulutination method and enzyme immunoassay for the antibodies to adult T-cell leukemia virus in the sera from healthy adults]. (1987) (0)
Effect ofHeatandFreshHumanSerumon theInfectivity ofHuman T-Cell Lymphotropic Virus TypeIII Evaluated with NewBioassay Systems (1985) (0)
Persistence of Human Immunodeficiency Virus and Vaccine Development (2019) (0)
Paradigm change in immune correlation: cellular or humoral? (2010) (0)
A process for preparing a mouse for receiving, differentiation and proliferation of diverse cell is suitable, and the mouse produced thereby their use (2001) (0)
Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages. (2007) (0)
CRITICAL INVOLVEMENT OF HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 TAX PROTEIN IN IL-2-INDEPENDENT TRANSFORMATION OF T-CELLS (1999) (0)
[Aberrant NF-kappaB2/p52 generation in Hodgkin lymphoma cells]. (2007) (0)
406. Determination of the Most Efficient Vector System for Gene Transduction into Dendritic Cells (DC) (2004) (0)
Review Article Aberration in Signal Transduction Pathway in Human T-Cell Leukemia Virus Type I-Infected T Cells (2000) (0)
Infection of HTLV-III/LAV IN HTLV-I-Carrying Cell Lines : Virological, Immunological and Cytological Aspects (1986) (0)
Epitope mapping of rat neutralizing monoclonal antibody against human immunodeficiency virus type-1 by a phage peptide library: comparison with ELISA using synthetic peptides. (1999) (0)
Is AIDS a TNF disease (2008) (0)
[Removal of human immunodeficiency virus by filtration with microporous regenerated cellulose membrane and by fractionation with polyethylene glycol]. (1989) (0)
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting (2012) (0)
489. Further Studies of the Most Efficient Vector Systems for Gene Transduction into Human Dendritic Cells Line (im-NMD) (2005) (0)
Title Retrovirus Entry by Endocytosis and Cathepsin Proteases (2017) (0)
Seroreactivity to HHV-6 polypeptides in infants with exanthema subitum and their mothers (1990) (0)
Inhibition of I Ô B kinase Ç restrains oncogenic proliferation of pancreatic cancer cells (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Naoki Yamamoto?

Naoki Yamamoto is affiliated with the following schools:

Naoki Yamamoto's Academic­Influence.com Rankings

Naoki Yamamoto's Degrees

Why Is Naoki Yamamoto Influential?

Naoki Yamamoto's Published Works

Published Works

What Schools Are Affiliated With Naoki Yamamoto?

Naoki Yamamoto's AcademicInfluence.com Rankings